These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34566975)
1. Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation. Liu J; Liu Y; Panda S; Liu A; Lei J; Burd I Front Immunol; 2021; 12():718563. PubMed ID: 34566975 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. Dobrzanski MJ; Reome JB; Dutton RW J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285 [TBL] [Abstract][Full Text] [Related]
3. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. Kemp RA; Ronchese F J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817 [TBL] [Abstract][Full Text] [Related]
4. In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype. Halverson DC; Schwartz GN; Carter C; Gress RE; Fowler DH Blood; 1997 Sep; 90(5):2089-96. PubMed ID: 9292548 [TBL] [Abstract][Full Text] [Related]
5. CD8+ tumor-specific Tc cells primed in vivo or in vitro against the BALB/c plasmacytoma ADJ-PC-5 use the same TcR V beta families but display distinct TC1 or TC2 characteristics. Becker C; Kölsch E; Pauels HG Immunobiology; 1997 Jun; 197(1):16-30. PubMed ID: 9241528 [TBL] [Abstract][Full Text] [Related]
6. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713 [TBL] [Abstract][Full Text] [Related]
7. Differential activation of CD8+ tumor-specific Tc1 and Tc2 cells by an IL-10-producing murine plasmacytoma. Specht C; Pauels HG; Becker C; Kölsch E Dev Immunol; 1998; 6(3-4):331-42. PubMed ID: 9814607 [TBL] [Abstract][Full Text] [Related]
8. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Vukmanovic-Stejic M; Vyas B; Gorak-Stolinska P; Noble A; Kemeny DM Blood; 2000 Jan; 95(1):231-40. PubMed ID: 10607707 [TBL] [Abstract][Full Text] [Related]
9. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells. Vinay DS; Kwon BS Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348 [TBL] [Abstract][Full Text] [Related]
10. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. Ochi H; Wu XM; Osoegawa M; Horiuchi I; Minohara M; Murai H; Ohyagi Y; Furuya H; Kira J J Neuroimmunol; 2001 Oct; 119(2):297-305. PubMed ID: 11585633 [TBL] [Abstract][Full Text] [Related]
11. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816 [TBL] [Abstract][Full Text] [Related]
12. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212 [TBL] [Abstract][Full Text] [Related]
13. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Delfs MW; Furukawa Y; Mitchell RN; Lichtman AH Transplantation; 2001 Mar; 71(5):606-10. PubMed ID: 11292288 [TBL] [Abstract][Full Text] [Related]
14. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Fowler DH; Gress RE Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730 [TBL] [Abstract][Full Text] [Related]
15. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Ma J; Shi LL; Deng YK; Wang H; Cao PP; Long XB; Zhang XH; Liu Y; Zeng M; Liu Z Clin Exp Allergy; 2016 Sep; 46(9):1162-75. PubMed ID: 27176491 [TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ Regulatory T Cells Decreased CD8+IL-4+Cells in a Mouse Model of Allergic Asthma. Li P; Li Z; Zhang G; Yang J; Chen J Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):369-378. PubMed ID: 31522445 [TBL] [Abstract][Full Text] [Related]
17. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Erdmann AA; Gao ZG; Jung U; Foley J; Borenstein T; Jacobson KA; Fowler DH Blood; 2005 Jun; 105(12):4707-14. PubMed ID: 15746085 [TBL] [Abstract][Full Text] [Related]
18. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression. Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061 [TBL] [Abstract][Full Text] [Related]
19. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. Helmich BK; Dutton RW J Immunol; 2001 Jun; 166(11):6500-8. PubMed ID: 11359800 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 infection protects against a Tc1-to-Tc2 shift in CD8(+) T cells. Gulzar N; Diker B; Balasubramanian S; Jiang JQ; Copeland KF Hum Immunol; 2011 Nov; 72(11):995-1000. PubMed ID: 21920400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]